Literature DB >> 11994252

Adverse neonatal and cardiac outcomes are more common in pregnant women with cardiac disease.

Samuel C Siu1, Jack M Colman, Sheryll Sorensen, Jeffrey F Smallhorn, Dan Farine, Kofi S Amankwah, John C Spears, Mathew Sermer.   

Abstract

BACKGROUND: Pregnant women with heart disease (HD) are at increased risk for cardiac (CV) complications. However, the frequency of neonatal (NE) complications in pregnant women with HD relative to pregnant women without HD has not been examined. METHODS AND
RESULTS: Pregnant women with HD were prospectively monitored during 302 pregnancies. The frequency of NE and CV complications was compared with those in a control group without HD during 572 pregnancies. The frequency of NE complications was higher in the HD group (18% versus 7%; HD versus controls). The NE complication rate was lowest in pregnancies of women age 20 to 35 years who did not smoke during pregnancy, did not receive anticoagulants, and had no obstetric risk factors: 4% in control patients, 5% in HD patients with no cardiac risk factors for NE complications (left heart obstruction, poor functional class, or cyanosis), and 7% in HD patients with > or =1 such risk factor. In contrast, the event rate in pregnancies of controls age <20 or >35 years who had obstetric risk factors or multiple gestation or who smoked was 11%. In the HD group, women age <20 or >35 years who had obstetric risk factors or multiple gestation, who smoked, or who received anticoagulants experienced an even higher NE complication rate (27% with no cardiac risks for NE events and 33% in the presence of >or =1 cardiac risk factors). The frequency of CV complications was higher in the HD group (17% versus 0%; HD versus controls).
CONCLUSION: Pregnant women with HD are at increased risk for both NE and CV complications. The risk for NE adverse events in pregnant women with HD is highest in those with both obstetric and cardiac risk factors for NE complications.

Entities:  

Mesh:

Year:  2002        PMID: 11994252     DOI: 10.1161/01.cir.0000015699.48605.08

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  34 in total

1.  Maternal and Fetal Outcomes of Admission for Delivery in Women With Congenital Heart Disease.

Authors:  Robert M Hayward; Elyse Foster; Zian H Tseng
Journal:  JAMA Cardiol       Date:  2017-06-01       Impact factor: 14.676

Review 2.  Pregnancy and congenital heart disease.

Authors:  Anselm Uebing; Philip J Steer; Steve M Yentis; Michael A Gatzoulis
Journal:  BMJ       Date:  2006-02-18

3.  [Heart diseases in pregnancy].

Authors:  Vera Regitz-Zagrosek; Christa Gohlke-Bärwolf; Annette Geibel-Zehender; Markus Haass; Harald Kaemmerer; Irmtraut Kruck; Christoph Nienaber
Journal:  Clin Res Cardiol       Date:  2008-09       Impact factor: 5.460

Review 4.  Heart failure in women.

Authors:  Anne L Taylor
Journal:  Curr Heart Fail Rep       Date:  2015-04

Review 5.  Mitral valve disease in pregnancy: outcomes and management.

Authors:  Sarah Tsiaras; Athena Poppas
Journal:  Obstet Med       Date:  2009-03-01

Review 6.  Pregnancy in adult congenital heart disease.

Authors:  J W Roos-Hesselink; P T E Ruys; M R Johnson
Journal:  Curr Cardiol Rep       Date:  2013-09       Impact factor: 2.931

7.  Pregnancy and contraception in young women with congenital heart disease: General considerations.

Authors:  Rachel M Wald; Mathew Sermer; Jack M Colman
Journal:  Paediatr Child Health       Date:  2011-04       Impact factor: 2.253

Review 8.  Pregnancy in women with valvular heart disease.

Authors:  Karen K Stout; Catherine M Otto
Journal:  Heart       Date:  2006-08-11       Impact factor: 5.994

9.  Causes and mechanisms of intrauterine hypoxia and its impact on the fetal cardiovascular system: a review.

Authors:  Damian Hutter; John Kingdom; Edgar Jaeggi
Journal:  Int J Pediatr       Date:  2010-10-19

10.  Congenital heart disease in pregnancy.

Authors:  Anselm Uebing; Michael A Gatzoulis; Constantin von Kaisenberg; Hans-Heiner Kramer; Alexander Strauss
Journal:  Dtsch Arztebl Int       Date:  2008-05-09       Impact factor: 5.594

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.